These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12960144)

  • 1. Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001.
    Murphy CE; Lansdown MR; Speirs V; Carder PJ
    Clin Cancer Res; 2003 Aug; 9(9):3514; author reply 3515. PubMed ID: 12960144
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence re: M. L. George et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
    Salgado R; Vermeulen PB; Van Marck E; Benoy I; Dirix L
    Clin Cancer Res; 2001 May; 7(5):1481-3. PubMed ID: 11350921
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
    Gunsilius E; Tschmelitsch J; Petzer AL
    Clin Cancer Res; 2001 Feb; 7(2):443-4. PubMed ID: 11234902
    [No Abstract]   [Full Text] [Related]  

  • 5. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
    Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
    Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: S. A. W. Fuqua et al., Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res.,63: 2434-2439, 2003.
    Speirs V
    Cancer Res; 2003 Dec; 63(24):9055. PubMed ID: 14695225
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
    Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ; Stonelake PS; Lip GY; Blann AD
    Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of serum vascular endothelial growth factor in breast cancer patients.
    Ferrero S; Nicoletti A; Ragni N
    Intern Med J; 2005 May; 35(5):310-1; author reply 311. PubMed ID: 15845119
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
    Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between plasma and serum vascular endothelial growth factor.
    Ferrero S; Colombo BM
    Am J Cardiol; 2006 Aug; 98(3):424-5. PubMed ID: 16860040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biomarkers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor in breast cancer.
    Byrne GJ; McDowell G; Agarawal R; Sinha G; Kumar S; Bundred NJ
    Anticancer Res; 2007; 27(5B):3481-7. PubMed ID: 17972505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine in plasma as a novel breast cancer marker.
    Ibusuki M; Fujimori H; Yamamoto Y; Ota K; Ueda M; Shinriki S; Taketomi M; Sakuma S; Shinohara M; Iwase H; Ando Y
    Cancer Sci; 2009 Sep; 100(9):1735-9. PubMed ID: 19538527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary re: N. J. McCarthy et al., microvessel density, expression of estrogen receptor alpha, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clin. Cancer Res., 8: 3857-3862, 2002.
    Colpaert CG; Vermeulen PB; Dirix LY; Van Marck EA
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3815-6; author reply 3816. PubMed ID: 14506176
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone receptor status as a prognostic factor in breast cancer patients with hepatic metastases treated by liver resection.
    Purnak T; Altundag K
    Ann Surg; 2007 Aug; 246(2):338; author reply 338. PubMed ID: 17667517
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
    Yamasaki T; Tsuda H; Imazeki N; Matsubara O
    Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.